Alemtuzumab and multiple sclerosis: therapeutic application

By Alireza Minagar   J Steven Alexander   Mohammad Ali Sahraian   Robert Zivadinov  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 3, 2010-03 ,pp. : 421-429

Informa Healthcare

Access to resources Recommend Favorite

Current evaluation of alemtuzumab in multiple sclerosis

By Coyle Patricia Katherine  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 1, 2014-01 ,pp. : 127-135

Informa Healthcare

Access to resources Recommend Favorite

On the Catalytic Activity of Autoantibodies in Multiple Sclerosis

By Ponomarenko N. A.   Durova O. M.   Vorob'ev I. I.   Suchkov S. V.   Gabibov A. G.  

Doklady Biochemistry & Biophysics, Vol. 395, Iss. 1-6, 2004-03 ,pp. : 120-123

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Spasticity in multiple sclerosis: results of a patient survey

By Oreja-Guevara C.  

International Journal of Neuroscience, Vol. 123, Iss. 6, 2013-04 ,pp. : 400-408

Informa Healthcare

Access to resources Recommend Favorite

Neutralising antibodies to IFN-&bgr; in patients with multiple sclerosis

By Bagnato Francesca   Riva Marco   Antonelli Guido  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 8, 2006-08 ,pp. : 773-785

Informa Healthcare

Access to resources Recommend Favorite